FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/03/051045 [Registered on: 24/03/2023] Trial Registered Prospectively
Last Modified On: 24/03/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A Clinical to compare the effects of two drugs hyperbaric Bupivacaine and hyperbaric Ropivacaine in caesarean section under Spinal Anaesthesia. 
Scientific Title of Study   Comparing the effect of hyperbaric Bupivacaine with hyperbaric Ropivacaine on the block characteristics in parturient undergoing caesarean section under spinal anaesthesia:A randomised double blinded study 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
A/206/REB-Comm(SP)/RIMS/2015/903/241/2022  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  MILLO TAMA 
Designation  Post Graduate Trainee 
Affiliation  Manipur University 
Address  Department Of Anaesthesia Regional Institute Of Medical Sciences Imphal Manipur

Imphal West
MANIPUR
795004
India 
Phone  8974354454  
Fax    
Email  mitma1454@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  MILLO TAMA 
Designation  Post Graduate Trainee 
Affiliation  Manipur University 
Address  Department Of Anaesthesia Regional Institute Of Medical Sciences Imphal Manipur


MANIPUR
795004
India 
Phone  8974354454  
Fax    
Email  mitma1454@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr A Jack Meitei 
Designation  Assistant Professor 
Affiliation  Manipur University 
Address  Department Of Anaesthesia Regional Institute Of Medical Sciences Imphal Manipur

Imphal West
MANIPUR
795004
India 
Phone  9774262996  
Fax    
Email  jack2k49@gmail.com  
 
Source of Monetary or Material Support  
Department Of Anaesthesiology,Regional Institute Of Medical Sciences,Imphal,Manipur 
 
Primary Sponsor  
Name  Dr Millo Tama 
Address  Regional Institute Of Medical Sciences,Imphal 
Type of Sponsor  Other [Post Graduate Trainee] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Millo Tama  Regional Institute Of Medical Sciences,Imphal,Manipur  Elective Surgery Modular Operation Theatre Complex (OT2),Department Of Anaesthesiology,Regional Institute Of Medical Science
Imphal West
MANIPUR 
8974354454

mitma1454@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Research Ethics Board, Regional Institute of Medical Sciences,Imphal  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  ICD-10-CM 082 
Patients  (1) ICD-10 Condition: 1||Obstetrics,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Hyperbaric Bupivacaine   Study participants will be randomised into 2 groups Comparator group will receive 2 ml of 0.5% Hyperbaric Bupivacaine intrathecally for spinal anaesthesia. 
Intervention  Hyperbaric Ropivacaine  Study participants will be randomised into two groups.Intervention group will receive the 2 ml of 0.5% of hyperbaric intrathecally for spinal anaesthesia.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  ASA I or ASA II
term Pregnant woman 
 
ExclusionCriteria 
Details  a. History of allergy to study drugs
b. Bleeding disorder-platelet count <50,000/micro litre, prothrombin time>14 sec International normalised ratio(INR)->1.5
c. Local site infection
d. Cardiac, respiratory diseases and kidney disorder, neurological deficit
e. Spinal deformity
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
1.The block characteristics
2.regression of the blockade
3.side effects (if any)
4.hemodynamic changes  
outcome will be assesed after the administration of local anaesthetic at predetermined interval and data will be assesed at the end of the year.  
 
Secondary Outcome  
Outcome  TimePoints 
1.BP,PR,
2.Onset sensory block 10
3.Time to attain T4-6
4.Time to two segment regression
5.Total duration Sensory block
6.Onset Motor block
7.Time to Complete Motor block
8.Time to rescue Analgesia
9.Side effects if any 
1.0,10,15,20,30,40,50,60(mt)
2.Assesed and recorded after spinal every 2 minutes till 10 Sensory block
3.Assesed and recorded after spinal every 2 minute till T4-6 level reached
7.Assesed and recorded as per bromage scale till complete block 2 minutes after spinal
8.Noted as per symptoms of patient
9.Note time if any side effects as per symptoms if any 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   27/03/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
A major problem with Spinal Anaesthesia is that the use of local anaesthetics has ocassionally associated with adverse cardiac and neurotoxic side effects requiring early intervention in the early intraoperative period. The study will be prospective randomised double blinded study to asses and compare the effects of intrathecal administration of low dose 0.5% (2ml) hyperbaric bupivacaine versus 0.5% (2ml) hyperbaric ropivacaine in parturients undergoing LSCS under subarachnoid block..
A total of 60 parturient will be selected for the study and divided into two groups of 30 patients each like Group A (n=30) and Group B (n=30). According to a computer generated randomised table,patients in group A will be administered 2 ml of 0.5% bupivacaine heavy and group B will be administered 2 ml of 0.5% ropivacaine heavy in the subarachnoid space L3-L4.The block characteristic alongwith regression of the blockade,side effects (if any) and the haemodynamic changes will be observed,assesed and recorded by blind investigator using the VAS,Modified Bromage Scale. The data obtained will be collected and analysed using student ’t’ test for continous data and Chi square test forcategorical data as and where appropriate.
 
Close